New in PHEO: A Roadmap for Improving US Health Care
In these commentaries, members of the editorial board of Population Health, Equity & Outcomes present their ideas for fixes to the US health care system that could guide health policy efforts post election.
Health Equity & Access Weekly Roundup: November 23, 2024
A Case for Iron Deficiency as a Marker of Inequality in Care Access and Treatment
Addressing Patent Hurdles, Payer Barriers, and Interchangeability
5 Things You Should Know About Long COVID
To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask
Frameworks for Advancing Health Equity: Wellness Way
Collaborating for Cancer Care Equity: Community and Academic Insights
Innovating Cancer Care Through Equity and AI: Vanderbilt’s Vision
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
As Myeloma Trials Tackle Frontline Treatment, Where Are the Black Patients?
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Key Takeaways on the Future of HER2 in NSCLC
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Implementing CRM Learnings and Utilization of Telehealth
Targeted Therapies, Genomic Profiling Revolutionize Breast Cancer Treatment
REMS Program Supports Use of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Safety Profiles of Neurokinin-Targeted Therapies for VMS
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Key Predictors of Survival in IPF: Findings From the IPF-PRO Registry
Elinzanetant and the OASIS Trials: Quality of Life and Symptom Relief
Innovations in Atherosclerosis Have Potential to Benefit Patients With CKD, HIV
To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask
Collaborating for Cancer Care Equity: Community and Academic Insights
Elevating Value in Cancer Care With Innovations, Accessibility, Equity
Recent Cohorts Aging Into Medicare Use More Counseling and Psychotherapy Than Past Cohorts
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
Geographic Variations and Facility Determinants of Acute Care Utilization and Spending for ACSCs
Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
Racial/Ethnic Disparities in Cost-Related Barriers to Care Among Near-Poor Beneficiaries in Medicare Advantage vs Traditional Medicare
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way
Navigating the Evolving Treatment Landscape of Metastatic Renal Cell Carcinoma
Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
Navigating the Evolving Landscape of HER2-Positive Early-Stage Breast Cancer: Considerations for Managed Care
Child Abuse: Responsibilities and Protection of the Reporter
